Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission

Vroegindewey, Maxime; van den Berg, Victor J.; Bouwens, Elke; Akkerhuis, Martijn; Oemrawsingh, Rohit; Asselbergs, Folkert; Lenderink, Timo; van der Harst, Pim; Ronner, Eelko; Umans, Victor; Kardys, Isabella; Boersma, Eric

doi:10.1016/j.ahj.2019.02.016

Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.

Additional Metadata
Persistent URL	doi.org/10.1016/j.ahj.2019.02.016, hdl.handle.net/1765/121002
Series	VSNU Open Access deal
Journal	American Heart Journal
Organisation	Department of Cardiology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vroegindewey, M., van den Berg, V. J., Bouwens, E. (Elke), Akkerhuis, M., Oemrawsingh, R., Asselbergs, F., Lenderink, T., van der Harst, P., Ronner, E., Umans, V., Kardys, I.& Boersma, E. (2019). Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission. American Heart Journal, 216, 143–146.https://doi.org/10.1016/j.ahj.2019.02.016

Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission

Publication

Publication

About

Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission

Publication

Publication

Workflow

Workflow

Add Content